Screener
Cohen & Steers CNS Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 32.9%-0.7pp | 32.2%-1.4pp | 32%-1.5pp | 33.8%+1.3pp | 33.6%+1.3pp | |
| Net margin | 28.8%-1.0pp | 27.5%-2.2pp | 27.6%-1.7pp | 29.7%+2.5pp | 29.8%+3.6pp | |
| Valuation | ||||||
| Market capitalization | $4.34B+14.2% | $3.21B-21.4% | $3.2B-31.4% | $3.35B-31.0% | $3.92B+7.0% | |
| Price / earnings | 25.8×+2.3× | 20.6×-5.4× | 20.9×-10.0× | 20.4×-15.5× | 24.2×-4.5× | |
| Price / sales | 7.4×+0.4× | 5.7×-2.1× | 5.8×-3.3× | 6.1×-3.7× | 7.2×-0.3× |
FAQ
- Where do Cohen & Steers's ratios come from?
- Every ratio is computed from Cohen & Steers's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
